• Contact us
  • UK +44 (0)1782 764428
  • US 919-504-4900

You are here: Home » Insight hub » News Releases » Lucideon to Lead Science for Industry Session at the World Biomaterials Congress

Lucideon to Lead Science for Industry Session at the World Biomaterials Congress

Lucideon is pleased to announce that it is leading a Science for Industry session on Thursday 19 May at the World Biomaterials Congress in Montreal, Canada.

Headed by Dr Xiang Zhang, Royal Society Industry Fellow, and Head of Medical Materials & Devices at Lucideon, the day-long session will bring together academia and industry leaders to discuss how scientific development and new biomaterials technologies can be successfully translated into product development and industrial and commercial applications.

The session will feature five themes:  cardiovascular, orthopaedic, controlled release, wound care and biomaterials and anti-infective strategies.  Speakers will include representatives from Boston Scientific, Medtronic, Stryker, Novartis and Secant Medical and from many of the world’s leading universities.  Presentations will focus on how biomaterials science and research influences product and materials technologies development, and how it helps to troubleshoot biomaterial-related problems with existing products.

Dr Xiang Zhang said:  “We are extremely pleased that the organisers of the World Biomaterials Congress agreed to include a special session on ‘Science for Industry’ in their 2016 program.

“Scientists around the world are working on many new and innovative technologies but we must never lose sight of the end goal:  to translate our scientific research into practical, successful and commercially-viable products and applications.”

Gemma Budd, Head of Healthcare Technologies at Lucideon, has helped Dr Zhang to put the program together.  She will be giving a presentation on inorganic controlled release drug delivery technologies, showing how research into using inorganic materials is being successfully translated into development programs, specifically those that centre around the next generation of abuse deterrent products.

The session has been put together by a number of leading scientists, including Hasan Uludag, Professor at the University of Alberta, J Paul Santerre, Professor at the University of Toronto, and Isabelle Catelas, Associate Professor and Canada Research Chair at the University of Ottawa.  Professor Catelas will be co-chairing the Science for Industry session.

28 April, 2016

Contact Us

Get in touch